DOROTHY WOMACK: Open Payments
NPI 1003590282 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,284 in 164 payments from 16 companies in 2025. Trend: 2023 $590 · 2024 $1,645 · 2025 $3,284
Food & beverage: $2,830Education: $454
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 12 | $459 |
| ABBVIE INC. | 32 | $423 |
| GENZYME CORPORATION | 16 | $413 |
| Janssen Biotech, Inc. | 15 | $335 |
| E.R. Squibb & Sons, L.L.C. | 19 | $317 |
| UCB, Inc. | 14 | $290 |
| Galderma Laboratories, L.P. | 17 | $238 |
| Novartis Pharmaceuticals Corporation | 12 | $229 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $167 |
| Lilly USA, LLC | 8 | $134 |
Products named: DUPIXENT, TREMFYA, Sotyktu, Bimzelx, NEMLUVIO, RINVOQ, SKYRIZI, COSENTYX.
Industry payments across TX — which companies pay providers there.
